Literature DB >> 1977662

In vivo monitoring of a cAMP-stimulated DNA-binding activity.

F Weih1, A F Stewart, M Boshart, D Nitsch, G Schütz.   

Abstract

The transcriptional activity of the tyrosine aminotransferase (TAT) gene is influenced by two major signal transduction pathways, by glucocorticoids and by glucagon acting via cAMP. We analyzed the effect of cAMP on protein-DNA interactions in vivo and on the transcription rate of the TAT gene. We demonstrate that a cAMP-responsive element (CRE) is located in a tissue-specific DNase I-hypersensitive region, 3.6 kb upstream of the start site of transcription. By using the genomic footprinting technique, we show that this sequence is occupied by protein in uninduced cells and that the in vivo footprint is transiently increased upon cAMP induction. Protein binding at the TAT-CRE correlates with the rate of transcription of the TAT gene. Cycloheximide treatment reveals that the genomic footprint is subject to rapid turnover; however, subsequent cAMP induction in the continued presence of cycloheximide restores the footprint partially. We conclude that as a part of the signal transduction pathway, a cAMP-dependent, post-translational modification increases the DNA-binding activity of a protein to the TAT-CRE and thereby stimulates the transcription rate of the TAT gene.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1977662     DOI: 10.1101/gad.4.8.1437

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  20 in total

1.  Ubiquitin-mediated degradation of tyrosine aminotransferase (TAT) in vitro and in vivo.

Authors:  A Ciechanover; J L Hargrove; S Gross-Mesilaty
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

2.  Elements in the first intron of the alpha 1(I) collagen gene interact with Sp1 to regulate gene expression.

Authors:  D J Liska; V R Robinson; P Bornstein
Journal:  Gene Expr       Date:  1992

Review 3.  Mechanisms of specificity in neuronal activity-regulated gene transcription.

Authors:  Michelle R Lyons; Anne E West
Journal:  Prog Neurobiol       Date:  2011-05-18       Impact factor: 11.685

4.  Regulation of tyrosine aminotransferase gene expression by glucocorticoids in quiescent and regenerating liver.

Authors:  L Baki; M N Alexis
Journal:  Biochem J       Date:  1996-12-15       Impact factor: 3.857

5.  cAMP increases the expression of human angiotensinogen gene through a combination of cyclic AMP responsive element binding protein and a liver specific transcription factor.

Authors:  C S Narayanan; Y Cui; S Kumar; A Kumar
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

6.  Activation of the tyrosine aminotransferase gene is dependent on synergy between liver-specific and hormone-responsive elements.

Authors:  D Nitsch; M Boshart; G Schütz
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

7.  The distal enhancer implicated in the developmental regulation of the tyrosine aminotransferase gene is bound by liver-specific and ubiquitous factors.

Authors:  D Nitsch; G Schütz
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

8.  Liver cells contain constitutive DNase I-hypersensitive sites at the xenobiotic response elements 1 and 2 (XRE1 and -2) of the rat cytochrome P-450IA1 gene and a constitutive, nuclear XRE-binding factor that is distinct from the dioxin receptor.

Authors:  J Hapgood; S Cuthill; P Söderkvist; A Wilhelmsson; I Pongratz; R H Tukey; E F Johnson; J A Gustafsson; L Poellinger
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

9.  In vivo protein-DNA interactions at the c-jun promoter: preformed complexes mediate the UV response.

Authors:  D Rozek; G P Pfeifer
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

10.  Cell-type-specific binding of the transcription factor CREB to the cAMP-response element.

Authors:  Hyunjoo Cha-Molstad; David M Keller; Gregory S Yochum; Soren Impey; Richard H Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.